Clinical Trial Update: Evaluation of Blood Vessel Formation in Endocrine Tumors

View source ↗

Summary

The National Cancer Institute-sponsored trial evaluating angiogenesis in endocrine tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endocrine Tumor
• Neuroendocrine Tumor

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lesions | Status: COMPLETED